nikolab
Active member
- Joined
- Feb 10, 2012
- Messages
- 86
- Reason
- PALS
- Diagnosis
- 04/2006
- Country
- SRB
- State
- Serbia
- City
- Nova Pazova
BrainStorm Cell Therapeutics Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting
NEW YORK & PETACH TIKVAH, Israel – March 13, 2013 – BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will be presenting the initial results of its Phase I/II ALS trial at the 65th Annual Meeting of the American Academy of Neurology (AAN) in San Diego, California, from March 16-23. BrainStorm's groundbreaking clinical trial data were selected for one of only twelve oral presentations in the Emerging Science Session on Wednesday March 20th.
Read more BrainStorm Cell Therapeutics - March 13, 2013
Nikola
NEW YORK & PETACH TIKVAH, Israel – March 13, 2013 – BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will be presenting the initial results of its Phase I/II ALS trial at the 65th Annual Meeting of the American Academy of Neurology (AAN) in San Diego, California, from March 16-23. BrainStorm's groundbreaking clinical trial data were selected for one of only twelve oral presentations in the Emerging Science Session on Wednesday March 20th.
Read more BrainStorm Cell Therapeutics - March 13, 2013
Nikola
